Table 3.
Study | Eligibility* | Random allocation | Concealed allocation | Baseline comparability | Blind subjects | Blind therapists | Blind assessors | Adequate follow-up | Intention-to-treat analysis | Between-group comparisons | Point estimates and variability | Total score | Quality |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dawson [21], 2016 | YES | 1 | 0 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 7 | GOOD |
Capone[22], 2017 | YES | 1 | 0 | 1 | 0 | 1 | 1 | 0 | 0 | 1 | 1 | 6 | GOOD |
Kimberley [23], 2018 | YES | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 10 | Excellent |
Wu [24], 2020 | YES | 1 | 0 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 7 | GOOD |
Dawson [17], 2021 | YES | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 10 | Excellent |
*Eligibility criteria is not included in the scoring of PEDro scale.